MHRA-2022-0048-V448

Type II variation for application MHRA-2022-0048. Type II variation: Shelf Life Extension for Crizotinabex — routine update

Variation Number
MHRA-2022-0048-V448
Type
Type II
Application
MHRA-2022-0048
Change
CHG-2021-0148
Status
Failed
Fee
€76,977
Submitted
—
Approved
—
Description

Type II variation: Shelf Life Extension for Crizotinabex — routine update